Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of T Specific Immune Response Against Delta-CD20 Peptide in Hematological Malignancies B

NCT02844491 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Besancon as lead sponsor.

NCT NCT02844491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02844491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of T Specific Immune Response Against Delta-CD20 Peptide in Hematological Malignancies B
Lead sponsor
Centre Hospitalier Universitaire de Besancon
Phase
Observational
Overall status
Terminated
Start date
January 22, 2013
Completion date
September 19, 2014
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematological malignancies b